Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anhydrous dextrose + aspirin + nitroglycerin + albuterol sulfate + epinephrine + diphenhydramine
- Development stage
- Unknown
- Lead developer
- Best Dental Kit
- Modality
- Small Molecules
- Administration
- Intramuscular, Inhalation, Oral, Sublingual
01
Overview
Anhydrous dextrose + aspirin + nitroglycerin + albuterol sulfate + epinephrine + diphenhydramine is a **small-molecule combination emergency kit product** used in dental and office settings for acute medical emergencies. The combination includes **epinephrine** for emergency treatment of type I allergic reactions and anaphylaxis, **albuterol sulfate** as a beta-2 adrenergic bronchodilator for bronchospasm, **diphenhydramine** as an H1 antihistamine for allergic symptoms, **nitroglycerin** as a vasodilator for angina or chest pain, **aspirin** as an analgesic and antiplatelet agent, and **anhydrous dextrose** as a rapidly available carbohydrate component. Based on the provided context, the most relevant intended emergency indication for the exact combination is support of management of **allergic reactions including anaphylaxis**, with epinephrine serving as the principal lifesaving pharmacologic component. The product is marketed as a preassembled emergency kit rather than a novel molecular entity.
- Brand names
- Basic Dental Emergency KitDeluxe Dental Emergency Kit
- Other names
- dental emergency kitanhydrous dextrose + aspirin + nitroglycerin + albuterol sulfate + epinephrine + diphenhydramine
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRB2 (β2)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)sGC (Soluble Guanylyl Cyclase)ADRB1 (β1)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on anhydrous dextrose + aspirin + nitroglycerin + albuterol sulfate + epinephrine + diphenhydramine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anhydrous dextrose + aspirin + nitroglycerin + albuterol sulfate + epinephrine + diphenhydramine.